Csm Advisors, LLC Bristol Myers Squibb CO Transaction History

Csm Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $5.61 Million - $6.73 Million	-91,245 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $22,524 - $26,258	-420 Reduced 0.46%	91,245 $5.69 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $2,958 - $3,465	-50 Reduced 0.05%	91,665 $5.43 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $39,622 - $43,148	-640 Reduced 0.69%	91,715 $6.13 Million
Q1 2021 May 21, 2021	BUY	$59.34 - $66.74 $5.48 Million - $6.16 Million	92,355 New	92,355 $5.83 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Csm Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Csm Advisors, LLC with notifications on news.